KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $122,955,000 | -10.9% | 6,491,812 | -9.6% | 7.37% | -28.3% |
| Q1 2020 | $137,941,000 | +17.4% | 7,180,700 | +17.2% | 10.27% | +43.3% |
| Q4 2019 | $117,463,000 | +109.2% | 6,127,434 | +5.0% | 7.17% | +29.0% |
| Q3 2019 | $56,156,000 | +61.5% | 5,837,434 | +0.6% | 5.56% | +125.9% |
| Q2 2019 | $34,761,000 | +15.4% | 5,803,227 | +12.5% | 2.46% | +29.3% |
| Q1 2019 | $30,128,000 | -33.2% | 5,158,884 | +7.3% | 1.90% | -42.6% |
| Q4 2018 | $45,070,000 | -45.2% | 4,810,078 | -0.4% | 3.32% | -25.1% |
| Q3 2018 | $82,205,000 | +1.5% | 4,827,078 | +1.3% | 4.43% | -15.3% |
| Q2 2018 | $80,993,000 | – | 4,767,078 | – | 5.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |